Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to ATP9A and SALL4
- Molecular classification
- Long non-coding RNA (lncRNA), Other (antisense RNA)
01
Overview
ENSG00000303179 encodes a long non-coding RNA (lncRNA) annotated as a novel transcript antisense to ATP9A and SALL4. As an antisense lncRNA, it does not encode a protein but may regulate the expression of overlapping or adjacent genes (ATP9A, SALL4) through various mechanisms such as transcriptional interference, RNA masking, chromatin modification, or participation in double-stranded RNA-dependent processes. These functions are inferred from the general roles of natural antisense transcripts, which can affect chromatin state, mRNA stability, and transcriptional activity of their sense counterparts. There is no evidence that this RNA is itself a therapeutic target or directly implicated in disease, nor are there data on drugs, safety, or biomarkers specific to this gene. Its function is best studied through its regulatory influence rather than as a conventional druggable target.
- Other names
- ENSG00000303179
02
Mechanism of action
Transcriptional interference, RNA masking, Double-stranded RNA (dsRNA)-dependent mechanisms, Chromatin remodeling
03
Biological functions
Regulation of gene expressionChromatin modification (potential, based on general antisense RNA literature)RNA interference and transcriptional silencing (potential)
04
Disease associations
Other (no direct disease link for this specific transcript, but antisense lncRNAs in general may regulate disease-associated genes)
Beyond the preview
Go deeper on Novel transcript, antisense to ATP9A and SALL4.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel transcript, antisense to ATP9A and SALL4.